Repligen reported $109.52M in Stock for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Agilent A:US $ 818M 27M
Align Technology ALGN:US $ 178.75M 28.11M
Bio Techne TECH:US $ 116.75M 6.76M
Biomarin Pharmaceutical BMRN:US $ 710.98M 2.95M
Bristol Myers Squibb BMY:US $ 2137M 184M
Bruker BRKR:US $ 730.2M 29.5M
Catalent CTLT:US $ 593M 65.1M
Charles River Laboratories CRL:US $ 194.34M 0.76M
Danaher DHR:US $ 2547M 123M
Dentsply International XRAY:US 539M 39M
Exact Sciences EXAS:US $ 89.81M 0.78M
Fluidigm FLDM:US $ 25.07M 3.18M
General Electric GE:US $ 17016M 486M
Illumina ILMN:US $ 380M 16M
Luminex LMNX:US $ 132.09M 8.96M
Mettler Toledo International MTD:US 350.16M 28.82M
Myriad Genetics MYGN:US $ 17.7M 6.9M
Nanostring Technologies NSTG:US $ 28.7M 4.26M
Orasure Technologies OSUR:US $ 48.17M 7.82M
Pacific Biosciences Of California PACB:US $ 17.98M 1.72M
Patterson Companies PDCO:US $ 770.37M 33.59M
Peregrine Pharmaceuticals PPHM:US $ 15.24M 3.37M
Perkinelmer PKI:US $ 513.43M 16.48M
Thermo Fisher Scientific TMO:US $ 4625M 283M
West Pharmaceutical Services WST:US $ 345.2M 35M